CIK: 0001839209 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value ($000): $1,229,786 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 10,497,277 | $766,301 | 62.3% | $61.99 | +19.1% | COM PAR $.01 | 457669307 |
| PCVX | VAXCYTE INC | 2,198,187 | $251,187 | 20.4% | $66.90 | +34.7% | COM | 92243G108 |
| GERN | GERON CORP | 22,038,773 | $100,056 | 8.1% | $3.90 | +16.6% | COM | 374163103 |
| KROS | KEROS THERAPEUTICS INC | 1,523,732 | $88,483 | 7.2% | $39.55 | +24.9% | COM | 492327101 |
| SMMT | SUMMIT THERAPEUTICS INC | 1,084,880 | $23,759 | 1.9% | $13.98 | 0.0% | COM | 86627T108 |